Aktienanalyse zu Trulieve Cannabis Corp (TRLV)TRLVTrulieve Cannabis Corp

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. The Company operates in regulated markets that require expertise in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including supercritical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, it utilizes distillation, purification, and manufacturing technologies to further refine extracts and transform them into a wide variety of finished products. Its brands include premium-tier brands Avenue, Cultivar Collection, and Muse; Modern Flower, Momenta, and Sweet Talk, and value tier brands Co2lors, and Roll One. It operates in the Healthcare sector.

Trulieve Cannabis Corp (TRLV) is currently trading at $10.01, which is significantly below the analyst price target of $15, indicating potential upside. However, the stock has a low RSI of 32.35, suggesting it is oversold, but the recent negative trend with a 5-day change of -6.19% and a year-to-date change of -15.03% raises concerns. The main risk is the significant net loss reported in Q2 2026, amounting to -$405,975,000, which could impact investor confidence.